Antimicrobial Drug Resistance

1. Front Matter

   Pages i-xxvi

   PDF

2. Gram-Positive Bacterial Drug Resistance – Clinical

   1. Resistance in Streptococcus pneumoniae

      • Lesley McGee, Keith P. Klugman

      Pages 681-693

   2. Antibiotic Resistance of Non-Pneumococcal Streptococci and Its Clinical Impact

      • Jari Jalava, Helena Seppälä

      Pages 695-714

   3. Enterococcus: Antimicrobial Resistance in Enterococci Epidemiology, Treatment, and Control

      • Anne Y. Chen, Marcus J. Zervos

      Pages 715-733

   4. Antimicrobial Resistance in Staphylococci: Mechanisms of Resistance and Clinical Implications

      • Lisa G. Winston, Henry F. Chambers

      Pages 735-748

   5. Resistance in Aerobic Gram-Positive Bacilli

      • David J. Weber, William A. Rutala

      Pages 749-759

3. Gram-Negative Bacterial Drug Resistance – Clinical

   1. Antibiotic Resistance in Neisseria

      • Margaret C. Bash, Durrie L. McKnew, John W. Tapsall

      Pages 763-782

   2. Mechanisms of Resistance in Haemophilus influenzae and Moraxella catarrhalis

      • Michael R. Jacobs

      Pages 783-801

   3. Enterobacteriaceae

      • David L. Paterson

      Pages 803-810

   4. Pseudomonas aeruginosa

      • David L. Paterson, Baek-Nam Kim

      Pages 811-817

   5. Acinetobacter

      • David L. Paterson, Anton Y. Peleg

      Pages 819-823

   6. Antimicrobial Resistance of Shigella spp., Typhoid Salmonella and Nontyphoid Salmonella

      • Herbert L. DuPont

      Pages 825-832

   7. Antimicrobial Resistance in Vibrios

      • Michael L. Bennish, Wasif A. Khan, Debasish Saha

      Pages 833-845

   8. Antimicrobial Resistance in Helicobacter and Campylobacter

      • Patrick F. McDermott, Joanne L. Simala-Grant, Diane E. Taylor

      Pages 847-863

   9. Pertussis (Whooping Cough)

      • Michael A. Saubolle

      Pages 865-871

   10. Antibiotic Resistance of Anaerobic Bacteria

       • Itzhak Brook

       Pages 873-899

   11. Mycobacteria: Tuberculosis

       • Francis A. Drobniewski, Yanina Balabanova

       Pages 901-915

   12. Drug Resistance by Non-Tuberculous Mycobacteria

       • Kathleen Horan, Gerard A. Cangelosi

       Pages 917-927

4. Fungal Drug Resistance – Clinical

   1. The Role of Resistance in Candida Infections: Epidemiology and Treatment

      • J. D. Sobel, R. A. Akins

      Pages 931-951

   2. Antifungal Resistance: Aspergillus

      • P. H. Chandrasekar, Elias K. Manavathu

      Pages 953-965

This ? rst edition of Antimicrobial Drug Resistance grew out of a desire by the editors and authors to have a comprehensive resource of information on antimicrobial drug resistance that encompassed the current information available for bacteria, fungi, protozoa and viruses. We believe that this information will be of value to clinicians, epidemiologists, microbiologists, virologists, parasitologists, public health authorities, medical students and fellows in training. We have endeavored to provide this information in a style which would be accessible to the broad community of persons who are concerned with the impact of drug resistance in our cl- ics and across the broader global communities. Antimicrobial Drug Resistance is divided into Volume 1 which has sections covering a general overview of drug resistance and mechanisms of drug resistance ? rst for classes of drugs and then by individual microbial agents including bacteria, fungi, protozoa and viruses. Volume 2 addresses clinical, epidemiologic and public health aspects of drug resistance along with an overview of the conduct and interpretation of speci? c drug resistance assays. Together, these two volumes offer a comprehensive source of information on drug resistance issues by the experts in each topic.

• Antimicrobial
• Aspects
• Clinical
• Handbook
• Hepatitis
• International Public Health
• Malaria
• Mayers
• Resistance
• bacterial pathogens
• epidemiological
• infection
• infections
• infectious
• public health issues
• infectious diseases

From the reviews:

“This book is a comprehensive guide to the state of the field as far as clinical practice is concerned. … There is good coverage of the wider spectrum of pathogens: viruses, fungi and parasites are addressed as well as bacterial infections. Each contribution is exhaustive and will appeal very much to the clinical microbiologist and infectious disease specialist. … This is certainly a reference book, and every diagnostic laboratory would derive value in having a copy on its shelves.” (Colin Howard, Microbiology Today, June, 2010)

• Executive Vice President & Chief Medical Officer, Idenix Pharmaceuticals, Cambridge, USA

  Douglas L. Mayers

Policies and ethics